AIP
HCAT icon

Almanack Investment Partners’s Health Catalyst HCAT Stock Holding History

Almanack Investment Partners’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,672
Closed -$17K – 598
2022
Q3 		$17K Buy
+1,672
New +$22.1K ﹤0.01% 398

Other funds holding HCAT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
DG
Daventry Group New York $133M AUM 32.28% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Almanack Investment Partners's HCAT Position: Q4 2022 in Review

Almanack Investment Partners sold out of Health Catalyst (HCAT) in Q4 2022, closing a stake of 1,672 shares — an estimated $17K sold.

Almanack Investment Partners first reported a position in HCAT in Q3 2022 and held it in 1 quarter. The position peaked at $17K in Q3 2022. 166 funds tracked by Wall St. Rank hold HCAT as of Q4 2022.

  • Almanack Investment Partners reported no remaining Health Catalyst position as of Q4 2022 after selling out during the quarter.
  • Almanack Investment Partners sold 1,672 Health Catalyst shares in Q4 2022, an estimated $17K.
  • Almanack Investment Partners first reported a position in Health Catalyst in Q3 2022 and held it in 1 quarter.
  • Almanack Investment Partners's Health Catalyst position peaked at $17K in Q3 2022.
  • 166 funds tracked by Wall St. Rank held Health Catalyst as of Q4 2022.

Based on Almanack Investment Partners's 13F filing for Q4 2022, filed 9 Feb 2023.